You are here

Article Text

Article menu
Download PDFPDF
Rare disease
CASE REPORT
Pleomorphic lipoma of the bulbar conjunctiva
  1. Emily Li1,
  2. Jonathan Silbert2 and
  3. John Sinard1
  1. 1 Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut, USA
  2. 2 The Eye Care Group, Waterbury, Connecticut, USA
  1. Correspondence to Dr Emily Li, emilyli019{at}gmail.com

Abstract

A 55-year-old woman presented with a painless, pink mass of the right eye bulbar conjunctiva that had been gradually increasing in size for the past 10 years. Excisional biopsy with histopathological analysis revealed a rare diagnosis of pleomorphic lipoma. There was no recurrence at last follow-up evaluation 6 months postoperatively. To the best of our knowledge, this represents the third case of pleomorphic lipoma of the bulbar conjunctiva reported to date.

  • ophthalmology
  • pathology
  • surgery

https://doi.org/10.1136/bcr-2018-226548

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Patient consent for publication Obtained.

    • Contributors EL, JSilbert and JSinard made substantial contributions to the conception or design of the work, or the acquisition, analysis or interpretation of data. EL, JSilbert and JSinard participated in drafting the work or revising it critically for important intellectual content. EL, JSilbert and JSinard give final approval of the version published. EL, JSilbert and JSinard agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.